Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis

BACKGROUND: Currently, there is no consensus on the efficacy and safety of lamivudine (LAM) plus tenofovir disoproxil fumarate (TDF) combination therapy versus lamivudine monotherapy in HBV/HIV coinfected patients. METHODS: A comprehensive literature search was performed in English and Chinese datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Aoran, Jiang, Xiaoyan, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130076/
https://www.ncbi.nlm.nih.gov/pubmed/30201035
http://dx.doi.org/10.1186/s12985-018-1050-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130076/
https://www.ncbi.nlm.nih.gov/pubmed/30201035
http://dx.doi.org/10.1186/s12985-018-1050-3

Ejemplares similares